Healthcare provider profile · identity verified

Matthew J Satcher, M.D.

Family Practice · DAMASCUS, OR · NPI 1386964310

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	692	191
Losartan Potassium	Losartan Potassium	413	108
Amlodipine Besylate	Amlodipine Besylate	401	110
Levothyroxine Sodium	Levothyroxine Sodium	382	102
Lisinopril	Lisinopril	381	100
Hydrochlorothiazide	Hydrochlorothiazide	285	80
Omeprazole	Omeprazole	270	93
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	230	38
Metformin Hcl	Metformin Hcl	225	63
Metoprolol Succinate	Metoprolol Succinate	221	65
Rosuvastatin Calcium	Rosuvastatin Calcium	217	73
Gabapentin	Gabapentin	207	62
Tamsulosin Hcl	Tamsulosin Hcl	195	64
Simvastatin	Simvastatin	175	45
Trazodone Hcl	Trazodone Hcl	175	46
Alendronate Sodium	Alendronate Sodium	172	52
Eliquis	Apixaban	161	41
Albuterol Sulfate Hfa	Albuterol Sulfate	143	33
Atenolol	Atenolol	128	33
Sertraline Hcl	Sertraline Hcl	128	36
Zolpidem Tartrate	Zolpidem Tartrate	126	20
Potassium Chloride	Potassium Chloride	124	33
Furosemide	Furosemide	121	41
Warfarin Sodium	Warfarin Sodium	112	30
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	105	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	98	24
Clopidogrel	Clopidogrel Bisulfate	94	29
Pantoprazole Sodium	Pantoprazole Sodium	93	30
Diclofenac Sodium	Diclofenac Sodium	89	34
Metformin Hcl Er	Metformin Hcl	84	23
Finasteride	Finasteride	82	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	18
Bupropion Xl	Bupropion Hcl	74	21
Carvedilol	Carvedilol	74	20
Lovastatin	Lovastatin	73	20
Venlafaxine Hcl Er	Venlafaxine Hcl	72	18
Duloxetine Hcl	Duloxetine Hcl	71	20
Oxycodone Hcl	Oxycodone Hcl	71	14
Metoprolol Tartrate	Metoprolol Tartrate	68	20
Jardiance	Empagliflozin	66	25
Lorazepam	Lorazepam	66	16
Allopurinol	Allopurinol	64	17
Pravastatin Sodium	Pravastatin Sodium	62	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	15
Tramadol Hcl	Tramadol Hcl	60	19
Alprazolam	Alprazolam	57	16
Pregabalin	Pregabalin	57	14
Naproxen	Naproxen	56	16
Amoxicillin	Amoxicillin	55	47
Glipizide Er	Glipizide	54	18
Citalopram Hbr	Citalopram Hydrobromide	52	13
Propranolol Hcl	Propranolol Hcl	52	17
Famotidine	Famotidine	51	13
Escitalopram Oxalate	Escitalopram Oxalate	50	14
Montelukast Sodium	Montelukast Sodium	48	19
Prednisone	Prednisone	48	31
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	14
Tizanidine Hcl	Tizanidine Hcl	45	20
Cephalexin	Cephalexin	44	34
Xarelto	Rivaroxaban	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	14
Ropinirole Hcl	Ropinirole Hcl	40	11
Celecoxib	Celecoxib	39	14
Estradiol	Estradiol	39	16
Ketoconazole	Ketoconazole	39	20
Triamcinolone Acetonide	Triamcinolone Acetonide	39	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	29
Synthroid	Levothyroxine Sodium	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	11
Glipizide	Glipizide	36	suppressed
Glimepiride	Glimepiride	34	12
Aripiprazole	Aripiprazole	32	11
Mounjaro	Tirzepatide	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Ozempic	Semaglutide	31	suppressed
Spironolactone	Spironolactone	31	11
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Acyclovir	Acyclovir	28	12
Fluticasone Propionate	Fluticasone Propionate	27	18
Mupirocin	Mupirocin	27	18
Azithromycin	Azithromycin	25	22
Chlorthalidone	Chlorthalidone	25	suppressed
Torsemide	Torsemide	25	12
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Ibuprofen	Ibuprofen	24	13
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Colchicine	Colchicine	23	15
Valacyclovir	Valacyclovir Hcl	23	12
Cefdinir	Cefdinir	22	19
Ezetimibe	Ezetimibe	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nystatin	Nystatin	17	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	11
Lactulose	Lactulose	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Ciclopirox	Ciclopirox	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Baclofen	Baclofen	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Temazepam	Temazepam	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Prevacid	Lansoprazole	11	suppressed
Ramipril	Ramipril	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error